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This paper compares the performance of two new directionally-sensitive multivariate
methods, based on the multivariate CUSUM (MCUSUM) and the multivariate exponen-
tially weighted moving average (MEWMA), for biosurveillance. While neither of these
methods is currently in use in a biosurveillance system, they are among the most promising
multivariate methods for this application. Our analysis is based on a detailed series of
simulations using synthetic biosurveillance data that mimics various types of disease back-
ground incidence and outbreaks. We apply the MCUSUM and the MEWMA to residuals
from an adaptive regression that accounts for the systematic effects normally present in bio-
surveillance data. We find that, much like the results from univariate CUSUM and EWMA
comparisons in classical statistical process control applications, the directionally-sensitive
MCUSUM and MEWMA perform very similarly.
1 Introduction
Biosurveillance is the process of monitoring health data in order to assess changes in disease
incidence. Traditional biosurveillance methods have been focused on retrospectively analyzing
medical and public health data, such as hospital admittance or mortality rates, to determine the
existence of a disease outbreak (Shmueli, 2006) and/or to conduct epidemiological investigations
(Stoto, 2007). Via traditional biosurveillance, the process of collecting and analyzing data can
take days, even weeks, before definitively concluding that an outbreak has occurred and alerting
officials. Improving on the timeliness of the alerts may help prevent spread of the disease and has
the potential to significantly improve effective response to an outbreak or bioterrorism attack,
particularly if the disease is contagious.
The Centers for Disease Control and Prevention (CDC) as well as many state and local
health departments around the United States have started to develop and field electronic bio-
surveillance systems (CDC, 2004). Making use of existing health-related data, often already in
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electronic form, these surveillance systems are intended to give early warnings of bioterrorist
attacks or other emerging health conditions. See Fricker et al. (2008), Fricker (2007a), Fricker
(2007b), Stoto (2007), Fricker and Rolka (2006), Shmueli (2006) and Stoto et al. (2006) for more
detailed discussions and related research.
Biosurveillance data frequently occurs in the form of discrete counts, such as daily counts
of chief complaints at a hospital. Chief complaints are broad categories – e.g., respiratory,
gastrointestinal, unspecified infection, or neurological – into which patients are grouped before
diagnosis. Chief complaint is the primary symptom or reason a patient sought care. Biosurveil-
lance might also be conducted on counts of positive lab test results, sales of over-the-counter
medical products, and calls to emergency call centers, for example.
Biosurveillance data is also frequently autocorrelated with seasonal cycles (e.g., the flu
season), trends (e.g., population changes), and other uncontrollable systematic features of the
data. Unlike in the traditional SPC setting, in which it is generally reasonable to assume that
under in-control conditions the data is independent and the distribution of the statistic being
monitored is stationary, this is generally not the case with biosurveillance data. Thus, if standard
SPC methods were applied to the raw data, signals would sometimes have an excessively high
probability of occurrence even when the process was “in-control” and, similarly, there would be
other times when the it would be excessively hard to signal even when the data was in an “out-
of-control” state. This often leads to the need to first model the data, in order to appropriately
adjust for or remove the known systematic features, and then to evaluate the “preconditioned
data” or the model residuals for evidence of an outbreak. (See Lotze, Murphy, and Shmueli,
2006, for further discussion.)
Current biosurveillance systems run multiple simultaneous univariate statistical process
control (SPC) procedures, each focused on detecting an increase in a single dimension. Mul-
tiple simultaneous univariate procedures have the advantages of ease of implementation and
interpretation, though they have the potential to be less sensitive to some types of changes
when compared to multivariate methods. This paper compares two new directionally-sensitive
multivariate methods based on the multivariate CUSUM (MCUSUM) and the multivariate ex-
ponentially weighted moving average (MEWMA). While neither of these methods is currently
in use in a biosurveillance system, they are among the most promising temporal multivariate
methods for this application.
Rogerson and Yamada (2004) evaluated multiple univariate CUSUMs versus a direction-
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ally invariant multivariate CUSUM for monitoring changes in spatial patterns of disease. Recent
work on directional multivariate procedures includes Joner et al. (2008); Fricker (2007a); Stoto
et al. (2006); and, building on the work of Follmann (1996), Perlman (1969), and Kudoˆ (1963),
Testik and Runger (2006). For a review of the use of SPC applications and methods in the
context of public health surveillance, see Woodall (2006).
The paper is organized as follows. In Section 2 the MCUSUM and MEWMA procedures
are described, including how they were applied to residuals from an adaptive regression-based
model. Section 3 describes how we generated synthetic background disease incident counts and
outbreaks, and Section 4 describes the comparison methodology, including how we determined
the form of the adaptive regressions used and how we selected various parameter values for the
MCUSUM and MEWMA procedures. Section 5 presents the results of the simulation compar-
isons and then illustrates the application of the methods on actual biosurveillance data from
five hospitals located in a large metropolitan area. The paper concludes in Section 6 with a
discussion of the implications of our findings and some recommendations.
2 Methods
In this section we first describe the MCUSUM and the MEWMAwith a focus on the directionally-
sensitive variants that are relevant to the biosurveillance problem. We then describe the “adap-
tive regression with sliding baseline” approach of Burkom et al. (2006). The use of adaptive
regression is motivated by the need to remove systematic trends commonly present in bio-
surveillance data and the MCUSUM and MEWMA are subsequently run on one-day ahead
(standardized) forecast errors which we assume are continuous.
2.1 Directional MCUSUM
Consider a p-dimensional set of observations at time t, Xt = {X1, . . . , Xp}. Crosier (1988)
proposed a MCUSUM that at each time t calculates the statistic
St = (St−1 +Xt − µ)(1− k/dt), if dt > k, (1)
where µ is the mean of Xt, k is a predetermined statistical distance, and dt = [(St−1 +Xt −
µ)′Σ−1(St−1 +Xt −µ)]








where Σ is the variance-covariance matrix of X. It concludes that a change has occurred at the
first time when Ct > h, for some pre-specified threshold h that achieves a desired average time
between false signals (ATFS). See Section 4 for a discussion of the ATFS metric.
In terms of choosing k, Crosier (1988) states, “In the univariate [CUSUM] case, the
quantity St−1 + (Xt − µ) is shrunk towards 0 by k standard deviations. If this is to hold for
the multivariate case, k must satisfy k′Σ−1k = k2 – that is, k must be of length k, where the
length is defined by using the covariance matrix Σ.”
The literature contains a number of MCUSUM procedures. In fact, the Crosier procedure
described above is one of a number of other multivariate CUSUM-like algorithms he proposed,
but Crosier generally preferred the above procedure after extensive simulation comparisons.
Pignatiello and Runger (1990) proposed other multivariate CUSUM-like algorithms but found
that they performed similar to Crosier’s. Healy (1987) derived a sequential likelihood ratio test
to detect a shift in a mean vector of a multivariate normal distribution. However, while Healy’s
procedure is more effective when the change is to the precise mean vector to be detected, it is
less effective than Crosier’s for detecting other types of shifts, including mean shifts that were
close to but not precisely the specified mean vector.
For the biosurveillance problem, an advantage of Crosier’s MCUSUM formulation is that
it is easy to modify to only look for positive increases. As described in Fricker (2007a), the mo-
tivation for this modification is the univariate CUSUM where directionality is achieved because
the CUSUM statistic is bounded below by zero. In the modified MCUSUM directionality is sim-
ilarly achieved by bounding each component of the cumulative sum vector by zero. In particular,
for detecting positive increases relevant to the biosurveillance problem, when dt > k limit St to
be non-negative in each dimension by replacing Equation (1) with St = (St,1, . . . , St,p) where
St,j = max[0, (St−1,j +Xt,j − µj)(1 − k/dt)],
for j = 1, 2, . . . , p.
2.2 Directional MEWMA
Lowry et al. (1992) introduced the MEWMA as a generalization of the univariate EWMA of
Roberts (1959). As with the MCUSUM, denote the mean forXt as µ and letΣ be the covariance
matrix. In the spirit of the reflected EWMA of Crowder and Hamilton (1992), the directionally
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sensitive MEWMA proposed by Joner et al. (2008) calculates
Zt =
{
max[0, λ(Xt − µ) + (1− λ)Zt−1], for t > 0
0, for t = 0
,
where the maximum function is applied componentwise. Zt is a weighted average of the current
observation standardized around 0 and the previous Z statistic. The parameter 0 < λ ≤ 1 is
the smoothing parameter which controls the weight assigned to the new observation vector. The




















The MEWMA signals an alarm whenever Et exceeds a predetermined threshold h which
is set to achieve a desired ATFS. If Et does not exceed h, then the MEWMA iterates through
the next time step with a new observation vector, recalculating the test statistic, and continuing
until such time as the Et > h.
2.3 Adaptive Regression with Sliding Baseline
We used the “adaptive regression model with sliding baseline” of Burkom et al. (2006) to model
and, to the greatest extent possible, remove the systematic components of biosurveillance data.
The basic idea is as follows. Let Yi be an observation, say chief complaint count on day i at
one of p hospitals. For each hospital, regress the observations from the past n days on time
relative to the current period. Then use the model to predict today’s observation and apply the
MCUSUM or MEWMA to the vector of the differences between today’s observed value and the
predicted value. Repeat this process each day, always using the most recent n observations as
the sliding baseline in the regression to calculate the forecast error.
For t > n, and assuming a simple linear formulation, the model for each hospital is
Yi = β0 + β1 × (i− t+ n+ 1) + ǫ (2)
for i = t − 1, . . . , t − n. Of course, as appropriate, the model can also be adapted to allow for
nonlinearities by adding a quadratic term or to allow for day-of-the-week effects by including
the appropriate indicator variables in Equation (2).
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Burkom et al. (2006) used an 8-week sliding baseline (n = 56). We compared the per-
formance for a variety of ns and between a linear and quadratic form of the model. Section 4.1
describes how we determined the form for the adaptive regression and the length of the sliding
baseline.
The model is fit using ordinary least squares, regressing Yt−1, . . . , Yt−n on n, . . . , 1. Hav-
ing fit the model, the forecast error is
rt = Yt −
[
βˆ0 + βˆ1 × (n+ 1)
]
,
where βˆ0 is the estimated intercept and βˆ1 is the estimated slope. If we denote the forecast
error for hospital j as rt(j), then the residual vector upon which the MCUSUM and MEWMA
are run is Xt = {rt(1)/σY (1), . . . , rt(p)/σY (p)}, where σY (j) is the standard deviation of the
dependent variable in the adaptive regression.
3 Simulating Biosurveillance Data
In order to compare the methods, we simulated a background disease incidence and then overlaid
various types of simulated bioterrorism attacks/natural disease outbreaks (which we will refer
to herein simply as “outbreaks”). The simulations were conducted in MatLab 7.1.0.246 using
the randn function to generate normal random variates. The simulations of both background
disease incidence and outbreaks are purposely idealized depictions designed to capture the main
features of biosurveillance data. The use of simulation and the idealization of the data features
were done for two very specific reasons:
• So that we could definitively compare and contrast the relative performance of the various
procedures under known conditions, and
• So that we could clearly distinguish how the various features of the data did or did not
affect each procedures’ performance.
The background disease incidence data was simulated as the sum of a mean disease
incidence, a seasonal sinusoidal cycle, and a random fluctuation. Outbreaks, when they occurred,
were incorporated as another additive term. That is, a daily observation Yt was simulated as
Yt = max(0,
⌈
m+ st + ot +N
⌉
), t = 1, 2, 3, . . . , (3)
where
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Scenario m A σ
1 90 80 30
2 90 80 10
3 90 20 30
4 90 20 10
5 90 0 30
6 90 0 10
Table 1: Parameters for Equation (3) for scenarios 1-6.
• m is the annual mean level of disease incidence;
• st is the seasonal deviation from the mean, calculated as st = A[sin(2πt/365)], where A
is the maximum deviation from m with t = 1 corresponding to October 1st on a 365 day
per year calendar;
• ot is the mean outbreak level which, when an outbreak is occurring, increases the disease
incidence level as described below;
• N is the random noise around the systematic component, modeled as N ∼ N(0, σ) inde-
pendently in each dimension; and,
• ⌈x⌉ is the ceiling function, which rounds x up to the next largest integer.
Table 1 specifies the parameter values for Equation (3) which define six “scenarios” de-
signed to span a range of possible underlying disease incidence patterns with large counts. The
parameters were selected to generate synthetic data that mimics disease incidence patterns simi-
lar to selected data sets at the CDC’s EARS simulation data sets (www.bt.cdc.gov/surveillance/
ears/datasets.asp). In particular, m = 90, A = 80, and σ = 30 or σ = 10 result in disease in-
cidence patterns similar to EARS data set S08. Setting m = 90, A = 20, and σ = 10 results
in disease incidence patterns similar to the S01 data set, as well as other patterns that are
intermediate between S01 and S08. The specific EARS data sets that we mimicked were chosen
in consultation with a CDC expert (Hutwagner, 2006).
Within each scenario we simulated four streams of data, representing say the chief com-
plaint counts from four large hospitals or perhaps the aggregate counts from four metropolitan
areas for one type of syndrome. Various combinations of A and σ result in various covariances
between the data streams. For example, A = 80 and σ = 10 result in ρ = 0.97 while A = 80 and
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σ = 30 result in ρ = 0.78. In comparison, A = 20 and σ = 10 result in ρ = 0.68 while A = 20
and σ = 30 result in ρ = 0.19. And, of course, A = 0 with either σ = 30 or σ = 10 results in
ρ = 0.
While these choices may seem either arbitrary or too restrictive, meaning they do not
characterize some particular pattern that occurs in a particular biosurveillance setting, we chose
them because they capture a wide range of data. Furthermore, as will be shown in Section 5, and
as was also demonstrated in Fricker et al. (2008) and Dunfee and Hegler (2007), the adaptive
regression turns out to be remarkably good at removing the systematic trends in the data so
that the specific choices made above are actually of little import and have little impact on the
final result.
Outbreaks were incorporated into Equation (3) as an additive term o(t) representing the
mean outbreak level, parameterized in terms of a peak magnitude M , a duration D, and a




M [2(t− τ + 1)/(D + 1)] , τ ≤ t ≤ τ +D/2− 1/2
M [1− (2(t− τ)−D + 1)/(D + 1)] , τ +D/2− 1/2 < t ≤ τ +D − 1
0, otherwise.
We evaluated the procedures’ performance for outbreaks of various magnitudes and du-
rations. We used three magnitudes – small, medium, and large – defined as a fraction of the
annual mean disease incidence m: M = 0.1m = 9, M = 0.25m = 22.5, and M = 0.5m = 45,
respectively. For all the scenarios we looked at durations that ranged from short to long:
D = 3, 5, . . . , 15 days. In the simulations, τ was the same in all dimensions, as was M and D.
So, when an outbreak occurred, it occurred at the same time and equally across all hospitals.
As we previously mentioned, the characterization of disease incidence in Equation (3) is
purposely idealized in order to facilitate comparison of the relative performance of the proce-
dures under various scenarios. The idea is to mimic the most salient and important features of
biosurveillance data in a simulation environment where we can know precisely when outbreaks
occur so that we can clearly assess and evaluate performance. That said, it is important to note
that the methods do not exploit the idealized features of the data and can be readily adapted
to account for those features of real data that are not included in Equation (3). For example:
1. Regular seasonal cycles. The seasonal cycle in Equation (3) is idealized and could be
exploited to make artificially accurate predictions. That is, not only do the cycles occur at
precisely the same time each year, but they are perfect sinusoids and they are synchronized
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across all data streams. However, since each data stream is modeled separately and because
the length of time over which the adaptive regressions are run is too short to model the
cycle (see Section 4.1), the MCUSUM and MEWMA procedures do not use the information
in the idealized seasonal cycle.
2. No linear trends. Growing or shrinking populations, or changes in health conditions, could
result in linear (or other) trends in the disease incidence. A trend term is not included in
Equation (3) since, if the procedures can appropriately adjust for the seasonal component,
they can also adjust for linear trends.
3. No day-of-the-week, holidays or other such effects. Dunfee and Hegler (2007) demon-
strated that adding day-of-the-week effects into Equation (3) made little difference in the
performance of the adaptive regression given a sufficiently long sliding baseline (roughly
n > 30 days or so). Hence we neither simulate day-of-the-week and other such effects as
an unnecessary complication that does not affect the results or conclusions. (However, we
do illustrate the application of the methods on actual biosurveillance data in Section 5,
the data for which do contain day-of-the-week effects.)
See Shmueli (2006), Lotze et al. (2006), and Burkom et al. (2006) for detailed expositions on
the features of biosurveillance data. See Fricker et al. (2008) and Dunfee and Hegler (2007)
for examples of how the adaptive regression methodology was able to account for and remove
day-of-the-week effects from synthetic biosurveillance data. See Kleinman et al. (2005) for an
alternate methodology designed to simulate biosurveillance data in both space and time.
4 Comparison Methodology
The metrics used to compare performance between procedures were: (1) the fraction of times a
procedure missed detecting an outbreak and (2) the average time to first outbreak signal (AT-
FOS). The former is a measure of detection capability while the latter is a conditional measure
of the timeliness of detection. The ATFOS is defined as the average time until the first signal
among all simulations for which a signal occurred during the outbreak period. Clearly perfor-
mance in both dimensions must be considered since a desirable procedure must simultaneously
have a short ATFOS and a low fraction of outbreaks missed. A procedure that is small in one
dimension while being large in the other is not particularly useful.
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This approach differs from much of the biosurveillance literature that attempts to evaluate
performance simultaneously in three dimensions: “sensitivity, specificity, and timeliness.” While
we do assess performance in terms of timeliness via ATFOS and fraction missed, a sensitivity-
like measure, we use a fixed average time between false signals (ATFS) in the third dimension
to simplify the analysis. In so doing, we assume that the relative performance of the procedures
does not change for other choices of ATFS.
This is similar to the approach used in the statistical process control (SPC) literature,
where the ATFS is roughly equivalent to the “in-control average run length” and the ATFOS
is equivalent to the “out-of-control average run length.” The average run length, or ARL, is
the average number of observations until a signal. In the SPC literature, it is the common
and well accepted practice to compare the performance of procedures by first setting thresholds
that achieve a specific in-control average run length and then compare out-of-control average
run lengths under various conditions. The procedure that demonstrates lower out-of-control
average run lengths across a variety of conditions deemed important is judged to be the better
procedure.
However, this approach differs from the SPC literature because we also use the fraction
missed metric. In the SPC literature, once a process goes out-of-control, it is assumed to stay in
that condition until a procedure signals and the cause is identified and corrected. Thus, once a
procedure goes out of control, any signal is a true signal. This is not the case in biosurveillance
where outbreaks are transient and after some period of time disappear. In this situation, it is
possible for a procedure to fail to signal during an outbreak, after which a signal is a false signal.
Returning to the biosurveillance literature’s “specificity” metric, we prefer ATFS because
the concept of specificity is not well defined in sequential testing problems. In classical hypothesis
testing, specificity is the probability that the null hypothesis is not rejected when it is true. It
is one minus the probability of a Type I error. In medicine, it is the probability that a medical
test will correctly indicate that an individual does not have a particular condition. However,
biosurveillance involves sequential testing where, in the absence of an outbreak the repeated
application of any procedure will eventually produce a false signal. Said another way, in the
absence of an outbreak, one minus the specificity for a sequential test must approach 100 percent
as the number of tests is allowed to get arbitrarily large.
In the biosurveillance literature, specificity is often (re)defined as the fraction of times a
procedure fails to signal divided by the number of times the procedure is applied to a stream of
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biosurveillance data without outbreaks (c.f., Reis et al. 2003). If the data is independent and
identically distributed from day to day, and if the test procedure results in test statistics that
are independent and identically distributed from day to day as well, then such a calculation is an
appropriate estimate of the specificity of a test on a given day. However, biosurveillance data are
generally autocorrelated and, even if it were not, any procedure that uses historical data in the
calculation of a test statistic will produce autocorrelated statistics. Under these conditions, it is
not clear what the quantity from the above calculation represents. It is certainly not specificity
in the classical hypothesis testing framework. See Fraker et al. (2007) for additional discussion.
So, for each scenario in Table 1, we determined the threshold for each procedure that
gave an ATFS of 100 days. The ATFS is a measure of the time between clusters of false signals.
It would be equivalent to the average time between signal events (ATBSE) metric of Fraker et
al. (2007) if they allowed the procedure to be reset to its initial condition after a “signal event”
and the data related to the signal event is removed from the adaptive regression. All other
things being equal, larger ATFS values are to be preferred.
The thresholds to achieve a particular ATFS were determined empirically as follows.
For a particular scenario and procedure, we chose an initial h and ran an algorithm r times
(starting with S0 = 0 or Z0 = 0), recording for each run i the time ti when the procedure
first signalled. The ATFS was estimated as
∑r
i=1 ti/r, and we then iteratively adjusted h and
re-ran the procedure to achieve the desired ATFS, eventually setting r large enough to make the
standard error of the estimated ATFS acceptably small (less than one day). Once the thresholds
were set, the procedures were then compared across all the scenarios specified in Table 1 for all
the outbreak types described in Section 3.
The purpose of setting the thresholds to achieve equal time between false alarms was to
ensure a fair comparison between the procedures. That is, it is always possible to improve a
procedure’s ability to detect an actual outbreak by lowering the threshold, but this comes at
the expense of also decreasing the ATFS. Thus, by first setting the thresholds to achieve equal
time between false alarms we could then make an objective judgement about which procedure
or procedure was best at detecting a particular type of outbreak.
Across all the scenarios in Table 1, the MCUSUM thresholds ranged from h = 3.25
to h = 3.31. For the MEWMA procedures, the thresholds ranged from h = 4.57 to h =
4.78. The variation is due to differences in the lengths of the sliding baseline for the adaptive
regressions used for each scenario and the resulting ability of the adaptive regressions to remove
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the systematic effects from the data. In the absence of a systematic component in the data (i.e.,
scenarios 5 and 6), we set h = 3.25 for the MCUSUM and h = 4.6 for the MEWMA.
Having set the thresholds to achieve equal ATFS performance, the ATFOS and fraction
missed were calculated as follows. For each iteration i, the procedures were run for 100 time
periods (using data from 100 + n time periods so that the adaptive regression could be fit for
period 1) without any outbreaks. If a procedure signalled during this time it was reset and
restarted, just as it would be in a real application, since the signal corresponded to a false
alarm. This allowed the Z100 and S100 statistics to be in a steady state condition at the time of
the outbreak. Outbreaks began at time 101 and continued for the appropriate duration. If the
procedure signalled at time ti within the duration of the outbreak, the time to first outbreak
signal was recorded as ti − 100 and the ATFS was estimated as
∑s
i=1(ti − 100)/s for the s
iterations that signalled within the outbreak duration. The fraction missed was calculated as
the number of iterations for which the procedure failed to signal during the outbreak divided by
the total number of iterations run.
4.1 Determining the Form of the Adaptive Regressions
When using regression to predict future observations, the question naturally arises as to how
much historical data should be used for the regression’s sliding baseline. Of course, all other fac-
tors being equal, regressions based on a shorter sliding baseline will less accurately estimate the
underlying systematic trends in the data than those based on longer sliding baselines. However,
while a longer sliding baseline should allow for a more detailed regression model and presumably
a better prediction, often in biosurveillance the amount of available data is limited or the older
data of questionable relevance due to changing trends or phenomena. Hence, there is a trade-off
to be made between the amount of historical data used in a particular model and the predictive
accuracy of that model.
As described in Dunfee and Hegler (2007), this led us to also determine and evaluate the
performance of the “optimal” sliding baseline (n) for each scenario (m,A, σ combination). For
each of the six scenarios we studied, we determined the optimal n to later use in the actual
regression analysis and method comparisons. In addition, two separate regression models were
evaluated in order to determine the best form of the model, either linear or quadratic.
Figure 1 shows an example of how we assessed the form of the adaptive regression and
determined the “optimal” sliding baseline for scenario 1 (m = 90, A = 80, σ = 30). The optimal
12





























Figure 1: Average squared residuals for linear and quadratic models as a function of the amount
of historical data – i.e., the size of the sliding baseline (n) – used to fit the regression models
under scenario 1. From this, we determined the best model was linear with an “optimal n” of
about 30 days.
n was chosen by visual inspection with the criteria that the n be as small as possible but also
as close to achieving the minimum average squared residual as possible. This means that we
chose the smallest n that achieved most of the reduction in the average squared residual and
not the n that occurred precisely at the minimum point on the curve. For example, in Figure 1
we determined that the “optimal n” was about 30 days for the linear model (and much larger
for the quadratic model).
Figure 1 shows that the linear model achieved close to the same minimum average squared
residual as the quadratic model at a much smaller n. As described in Dunfee and Hegler (2007),
this occurred consistently for all of the scenarios leading us to choose a linear adaptive regression
model in all of our evaluations. For the linear model, across all the scenarios, the optimal ns
ranged from 30 to 45 days. For other scenarios with day-of-the-week effects, not described here
(see Fricker et al., 2008), the optimal ns were even larger with the largest being around 56 days
– the size recommended by Burkom et al. (2006).
4.2 Determining λ for the MEWMA and k for the MCUSUM
In order to compare the MEWMA and MCUSUM under a variety of biosurveillance scenarios,
we wanted to first set their parameters such that they performed as similarly as possible under
the standard statistical process control assumptions of iid observations and a sustained jump
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change in the mean. To do this, we first fixed λ for the MEWMA and then searched for the
value of k in the MCUSUM that matched its performance to the MEWMA’s.
Setting λ is a trade-off between how much emphasis is put on past information in the
MEWMA statistic and the desire for the MEWMA to be as sensitive as possible to changes
in X. The idea is that, in both the univariate and multivariate EWMA, larger λs put more
weight on the current observation and less on past observations. At its most extreme, setting
λ = 1 turns the univariate EWMA into a Shewhart procedure. Montgomery (2001) recommends
setting 0.05 ≤ λ ≤ 0.25 for the univariate EWMA and, given the emphasis on timeliness in this
application and based on our experience (c.f. Chang and Fricker, 1999), we thus chose to set
λ = 0.2.
Having fixed λ, we conducted simulation comparisons over various values of k to find
that value for which the MCUSUM performed as closely as possible to the MEWMA. We did
this by comparing how well the MCUSUM detected various sustained mean shifts for a four
dimensional standard multivariate normal. As shown in Figure 2, we found that k = 0.74 gave
the closest performance to the MEWMA with λ = 0.2, where we set all of the components of
the k vector equally (e.g., for k = 0.74 we set k = {0.37, 0.37, 0.37, 0.37}).
Figure 2: Comparison of the MCUSUM for various k to the MEWMA with λ = 0.2 in terms of
the ratio of the MCUSUM ATFS to the MEWMA ATFS. The MCUSUM with k = 0.74 came
closest to matching the MEWMA’s performance over a wide range of mean shifts.
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In particular, Figure 2 shows the percent change in the ATFS (which, in this case, is
the same as the average run length measure, or ARL, used in the traditional statistical process
control literature) for the MCUSUM for various k compared to the MEWMA. In the plot we see
that the MCUSUMs with k < 0.74 signal faster than the MEWMA for small mean shifts and
signal slower as the mean shift increases. Conversely, as k increases from 0.74, the MCUSUM
begins to signal slower than the MEWMA for small shifts and much faster as the mean shift
increases. Ultimately, we found that the MCUSUM with k = 0.74 had the closest performance
over a wide range of shifts: it achieves almost precisely the same ATFS for shifts between about
0.6 and 2.0, and is at most about five percent off over the entire range of shifts considered, from
0 to 2.0.
5 Results
In this section we compare the MCUSUM to the MEWMA, first using the simulated biosurveil-
lance data and then on actual data. In both cases we use simulated or real data that consist of
daily counts.
5.1 Simulation Comparison Results
Figures 3 and 4 summarize our main finding: the MEWMA and MCUSUM performed virtually
identically, both in terms of ATFOS and percent missed, across all the scenario and outbreak
combinations we evaluated. Though the lines deviate slightly in Figures 3 and 4, the differences
are not statistically significant. See Hu and Knitt (2007) for details.
Specifically, in Figure 3 we see that there is no difference in MCUSUM and MEWMA
performance for scenario 4 across all the types of outbreaks, from small to large magnitudes and
for all the durations. This result was also true for the other five scenarios. For example, Figure
4 shows the results for scenarios 1, 3, and 5 for an outbreak of medium magnitude. See Hu and
Knitt (2007) for plots for all of the scenarios and types of outbreaks.
Figure 3 demonstrates how the procedures perform for the various types of outbreaks. For
example, the ATFOS plots show that outbreaks of small magnitude and of three days duration
will only be detected about 30 percent of the time and, when detected, it will take about two
days on average for either the MCUSUM or MEWMA to signal. As the outbreak magnitude
increases, the procedures detect virtually all of the outbreaks and the ATFOS decreases to
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about one day for the largest magnitude outbreak. In comparison, for durations of 15 days, the
methods detect almost 70 percent of the small magnitude outbreaks and again virtually all of
the larger outbreaks. For the small magnitude outbreaks the average time to signal is about six
days, for the medium magnitude it is just under five days, and for the large magnitude outbreak
it is about 2-1/2 days.
Figure 4 demonstrates that the adaptive regression with sliding baseline methodology
does very well at removing the systematic component, at least for our synthetic biosurveillance
data. In this case, the systematic component is the seasonal sinusoid where, at the top the
sinusoid is large (A = 90), in the middle it is medium sized (A = 20), and at the bottom it is
non-existent (A = 0). In terms of ATFOS, there is no visible difference between the three plots
in Figure 4. In terms of percent of outbreaks missed, there is a slight degradation in the number
of outbreaks caught as the amplitude increases. However, these plots demonstrate that, overall,
the adaptive regression is quite effective at accounting for the systematic trends in the data.
5.2 A Comparison Using Actual Biosurveillance Data
In this section we compare how the procedures perform on actual biosurveillance data using
respiratory chief complaint counts for five hospitals located in one metropolitan area from Oc-
tober 1, 2001 to March 31, 2004. We focus on respiratory chief complaint data since it tends to
include those patients who come to emergency rooms with the flu and flu-like symptoms, which
could also be leading indicators of certain bioterrorism agents (Espino, 2001).
As originally described in Fricker (2007a), Figure 5 shows the respiratory chief complaint
count data by hospital with a four week centered moving average overlaid. A number of features
of the data are clear from the figure, including:
• The hospital moving averages do not exhibit increasing or decreasing trends, indicating
the long-term incidence rate for respiratory chief complaints is relatively constant.
• There are significant differences in mean counts between hospitals, indicating that some
hospitals either serve larger populations or serve populations with higher respiratory illness
rates (or both), as well as significant variation in the raw counts around the smoothed
mean.
• The hospital counts are positively correlated where, using the first six months of the data,
the correlations between all pairs of hospitals lie in the interval 0.0 ≤ r ≤ 0.49.
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• There are visible “events” in the data that persist for periods of time. For example,
there are peaks across most or all of the hospitals in March-June 2003 and December
2003-January 2004 that likely correspond to flu outbreaks.
The visible “events” are most likely naturally occurring flu outbreaks. They are consistent
with the CDC’s aggregate data on “percentage of visits for influenza-line illness reported by
sentinel physicians.” Specifically, the CDC (2005) characterized flu incidence in the South
Atlantic region of the United States (where the hospitals are located) as follows.
• The 2002-2003 flu season was “mild” with the percentage of visits in the South Atlantic
region peaking in February-March 2003. “Sporadic activity” was also reported in April
and May 2003.
• The 2003-2004 flu season “began earlier than most seasons and was moderately severe.”
The percentage of visits in the South Atlantic region peaked in December 2003.
5.2.1 Implementation
To implement the procedures, we divided the data up into a “historical” set of data, consisting
of the first six months (10/1/01-3/31/02), and a “future” set of data – the remaining two plus
years (4/1/02-5/17/04). As one would do in practice, the idea was to use the “historical” data to
estimate various quantities necessary for the procedures and then to illustrate each procedures’
performance on the “future” data.
Following the approach of Burkom (2006), we transformed the data using the started log
and then used the first eight weeks of data (10/1/01-11/25/01) as the initial sliding baseline
for an adaptive regression. Given that day-of-the-week effects were present in the data, the
adaptive regression was appropriately parameterized to include indicator variables in order to
account for such effects. The regression was used to predict the started log transformed counts
for day 57 and to calculate the resulting residuals. We then incremented the sliding baseline,
calculated the prediction residuals for day 58, and continued on through the remainder of the
first six months of the data, calculating the prediction residuals through day 182 (3/31/02).
From this, we used the prediction residuals from 11/26/01 to 3/31/02 to estimate the
standard deviations of the started log transformed counts for each of the hospitals, which we
then used to standardize the residuals and to estimate the variance-covariance matrix of the
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standardized residuals. For the “future” data, the standard deviations were also used to stan-
dardize the future adaptive regression residuals and the estimated variance-covariance matrix
was used in the two procedures as described in Section 2.
The remaining parameters for the MCUSUM and MEWMA were determined based on
the results of the previous simulations: we set k = 0.74 for the MCUSUM and λ = 0.2 for
the MEWMA. For the thresholds, as in the simulations, we set h = 4.6 for the MCUSUM and
h = 3.25 for the MEWMA and in order to achieve an ATFS of approximately 100 days.
5.2.2 Performance Comparisons
Figure 6 displays the signal times for the MEWMA and MCUSUM when they are run on the
“future” respiratory data. The figure shows the smoothed means (of Figure 5) and first signal
times overlaid. (“First signal time” means that repeated signals within 60 days after the first
signal are suppressed for plot clarity.) What this figure shows is that the modified MCUSUM
and the MEWMA performed extremely similarly. Specifically, seven of the eight first signal
times occurred on exactly the same day for both procedures. The only signal that differed
was the one on September 24th, where the MEWMA signaled on that day and the MCUSUM
signaled on September 25th.
Furthermore, not shown on the plot are the other signals, of which 24 matched again to
the day, three differed by only one day, and in only once case did one procedure (the MEWMA)
signal without the other signaling. The net result is that the two procedures performed almost
identically, with the small observed differences potentially attributable to the imprecision in
the setting of the procedures’ parameters and thresholds. Simply put, there was no practical
difference, and almost no quantitative difference, in the performance of the MCUSUM and the
MEWMA.
Figure 6 also gives some insight into how the procedures would perform in the real world.
Specifically, we see that the methods do detect the flu outbreaks (the gray shading highlight
the flu periods that the CDC identified for the South Atlantic region of the U.S.) with signals
on February 17, 2003 and December 20, 2004. The former is consistent with an up-tick in the
counts for the top hospital and the latter for up-ticks in four of the five hospitals. Also, the
signal on September 24, 2003 is consistent with up-ticks in the counts of at least two of the
five hospitals, even though this was not identified as a flu period. The other five signals are
not related to obvious up-ticks in the counts, though that is certainly subject to interpretation.
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However, even if they are false signals, they are within the expected number of false signals
based on an ATFS of 100 days.
6 Discussion
In this section we summarize our findings on the MEWMA and MCUSUM comparisons and dis-
cuss some thoughts about applying these and similar methods to the practice of biosurveillance
that arose during the course of the research.
6.1 MCUSUM or MEWMA?
When we began this research we fully expected to identify scenarios in which the MCUSUM
performed better than the MEWMA and vice versa. That the two procedures performed prac-
tically identically is an unexpected surprise. It is a surprise because, while it is well-known that
with the appropriate choice of parameters the univariate EWMA and CUSUM can be made
to perform similarly in standard SPC applications, the directional MEWMA and MCUSUM
described herein are neither the exact multivariate analogues of their univariate counterparts
nor is the biosurveillance problem the same as the standard SPC application.
Because there is seemingly no performance advantage in using one method over the other,
this result leads us to prefer the MEWMA for procedural reasons. Specifically, it is relatively easy
to develop an intuitive appreciation for how to choose λ and much more difficult to understand
how to appropriately choose k. That is, unlike the k in the univariate CUSUM which has a clear
interpretation, namely it is one-half of the smallest mean shift that is to be detected quickly, the
k in Crosier’s MCUSUM is a parameter in a multiplicative “shrinkage factor” for which there is
no literature or research to guide one in the trade-offs that must result from various choices of
k.
6.2 Managing the False Alarm Rate
In the application of MCUSUM and the MEWMA to the hospital respiratory chief complaint
data, the MCUSUM produced a total of 35 signals and the MEWMA 36 signals over a two-
year period. Given the on-going concerns with excessive false alarms in existing biosurveillance
systems, it is worthwhile to assess how we got so many alarms when we set the thresholds to
achieve an ATFS of 100 days.
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In our application, a majority of the additional signals were redundant signals seemingly
related to continuing outbreak conditions. In biosurveillance these types of redundant signals
will tend to naturally arise as a result of the autocorrelation present in the data, both because
outbreaks are persistent in time and because the adaptive regression residuals are not completely
independent. For example, the first signal on June 12, 2003 was followed by nine more signals
in the five weeks that followed it – one signal every 3-5 days (where the time between the
signals occurred because the MCUSUM and MEWMA statistics were reset after each signal
and thus it took a couple of days to the procedures to re-signal). Similarly, the first signal on
December 20, 2003 was followed by 10 more signals, one every day or two right after the first
signal subsequently spreading out to about a week apart later.
These types of continuing signals suggest a need for operator override capabilities in
biosurveillance systems so that the operator can, for example, silence future signals once an
outbreak is identified, much as one might silence a fire alarm once the fire trucks arrive. One
can imagine, for example, a biosurveillance system designed so that once a procedure signals, is
investigated, and an outbreak is confirmed – say it is a winter flu outbreak – the operator can
denote the start of the outbreak in the system and turn off the signals until such time as the
disease incidence rate returns to normal. For the application in Section 5, once these redundant
signals are eliminated the number of seemingly true signals (two or three) plus the number of
seemingly false first signals is reasonably close to what would be expected based on the chosen
ATFS.
6.3 Biosurveillance for Bioterrorism Detection
The idea of silencing future signals once a natural disease outbreak occurs begs the question of
the purpose of a biosurveillance system and whether during a winter flu outbreak the system
should still be looking for a bioterrorism attack. Indeed, if the overriding goal is bioterrorism
detection, then silencing the detection procedure during the flu season may be exactly the
wrong thing to do. Furthermore, if that is the goal, then during a natural disease outbreak the
biosurveillance systems will likely require “adjustment” to best detect a bioterrorism attack.
For example, consider the methods presented here or, for that matter, any method based
on the adaptive regression with sliding baseline. If such a method is simply automatically
implemented, as we did with the real data in Section 5, then an attack that occurs during a
natural disease outbreak will be very difficult to detect. It will, of course, be difficult to detect
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anyway, but with a long sliding baseline the redundant signals that will occur as a result of the
disease outbreak will be indistinguishable from the signals related to the attack.
Furthermore, the only way to (try to) identify an attack when an outbreak is occurring
is to adjust the sliding baseline of the adaptive regression so that it only includes data from the
outbreak period. If the outbreak is long enough that a reasonable new sliding baseline can be
established, then it may be possible to look for signals that indicate a further departure from the
outbreak. However, if that is the case, then the biosurveillance system will of necessity require a
“human-in-the-loop” to identify the start of the flu season and to re-set the adaptive regression
so that the sliding baseline only uses the flu outbreak data.
6.4 Can Biosurveillance be Automated?
While there is significant interest in the research and public health communities in devising
automated methods of detection capable of sifting through masses of data to identify outbreaks
and bioterrorism attacks, this research leads us to conclude that, at least for the foreseeable
future, these types of detection algorithms alone will not be sufficient and human-in-the-loop
strategies will be required for effective detection.
For example, the implementation of adaptive regression can be improved with the appli-
cation of human judgement. As just described, if the purpose is bioterrorism detection, then
the baseline should be adjusted – to the extent feasible – during natural disease outbreaks in
order to make bioterrorism detection possible during such outbreaks. This can only be done by
a human making an informed decision about when the outbreak started.
In a related vein, if the goal of a biosurveillance system is to detect departures from
the natural background disease incidence, then the performance of the adaptive regression im-
mediately after an outbreak will be improved by removing the outbreak data from the sliding
baseline. That is, inclusion of the outbreak data could impair the accurate estimation of pre-
dicted values immediately following the outbreak. This again will require a human making an
informed decision about both when an outbreak started and when it ended.
Finally, we note that simply allowing an adaptive regression to automatically proceed
sequentially through biosurveillance data without removing outbreak data (as we allowed out of
convenience in our example in Section 5) can result in false signals. This can occur when, for
example, the sliding baseline consists mainly of the data during the period when an outbreak
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is subsiding, such that the slope of the regression is negative. Under this condition, if there
is an abrupt return to the normal condition, then it is possible for the adaptive regression to
under-predict, resulting in positive residuals and an alarm condition.
Simply put, to the adaptive regression methodology, a sudden increase from the back-
ground disease incidence pattern looks the same as a sudden leveling off from an outbreak
returning back to a normal condition. And, while one might be tempted to not allow signals
when, say, the slope of the adaptive regression is negative, this would also prevent the procedure
from detecting outbreaks or attacks during periods when there are even slight improvements in
disease incidence.
Of course, while this discussion has focused on the application of adaptive regression, the
underlying issues are broader and not limited to just adaptive regression-based methods. This
suggests that improvements in the practice of biosurveillance will continue to require advances
in detection algorithms combined with development of detection algorithm practices and proce-
dures as defined over time by experienced biosurveillance system operators and enhancements
in biosurveillance system software capabilities.
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Figure 3: Performance of the MCUSUM and MEWMA under scenario 4 for three magnitudes
of outbreaks – M = 9, M = 22.5, and M = 45, shown from top to bottom – versus various
outbreak durations.
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Figure 4: Performance of the MEWMA and MCUSUM for m = 90, σ = 30, and M = 22.5 for
three magnitudes of amplitude – A = 90, A = 20, and A = 0, shown from top to bottom –
versus various outbreak durations for M = 22.5.
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Figure 5: The data consisting of “chief complaint” respiratory counts for five hospitals with
a smoothed mean line superimposed. The smoothed mean was calculated using a four week
moving average from two weeks prior to two weeks after each day.
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Figure 6: This plot shows when the modified MCUSUM and MEWMA first signaled when run
on the future data. “First signaled” means that repeated signals within 60-days of the first
signal are suppressed for plot clarity. The shaded areas indicate the flu seasons as indicated by
the CDC’s aggregate data on “percentage of visits for influenza-line illness reported by sentinel
physicians.”
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